In these diseases, various pathogenic proteins have been identified as the substrates of CMA, such as α-synuclein in PD [60], Tau protein in AD [61], huntingtin (Htt) in HD [62,63], and TDP-43 in ALS and FTLD [64,65]. The gene discussed is MAPT; the disease is Huntington disease.